Le Lézard
Classified in: Health
Subjects: NPT, PDT

Disaster Relief Non-profit All Hands and Hearts Launches Program in Western Ukraine for Internally Displaced People (IDPs)

UZHHOROD, Ukraine, Feb. 23, 2024 /PRNewswire/ -- All Hands and Hearts (AHAH), a non-profit organization that provides community-inspired, volunteer-powered disaster relief to international communities, has launched a crisis relief program in Western Ukraine two years after Russia's brutal invasion.

All Hands and Hearts is launching a volunteer program in Western Ukraine to support crisis-relief work for IDPs.

Since the invasion, All Hands and Hearts has been addressing the unique needs of Ukrainian refugees and internally displaced people (IDPs) through the Ukraine Crisis Relief program. In the early days of the crisis, working alongside local partner Save Ukraine, initial relief work encompassed supporting over 100,000 Ukrainians through life-saving evacuations and providing critical access to essential supplies.

Over the last two years, AHAH has adapted its work to the changing needs of these communities.

From July 2022 - March 2023, AHAH worked in Przemy?l, Poland, to conduct vital shelter repairs for those fleeing conflict and needing warm living spaces during the winter months. Since March 2023, AHAH has continued critical construction projects and working alongside local organizations to support the rapidly increasing refugee communities in Krakow, Poland.

All Hands and Hearts has evolved its partnership with Save Ukraine to facilitate the construction of transitional homes for 170 families. In November, AHAH spent two months in Western Ukraine, leveraging local partnerships to coordinate non-food items, conduct collective center repairs and coordinate inclusive and accessible engagement activities for IDPs.

As of January 2024, 14.6 million Ukrainians still need humanitarian assistance.

In March 2024, AHAH will launch a volunteer-powered program in Uzhhorod, Ukraine, in the Zakarpatska Oblast. Over 113,000 registered IDPs reside in the region, and more are expected to arrive as resources dwindle in outside areas. The city of Uzhhorod, therefore, needs support to provide safe shelter for displaced families and individuals.

AHAH will work with Uzhhorod University to provide critical updates and repairs for living spaces and coordinate various engagement activities for IDPs, giving dignity, community and shelter to over 200 individuals.

AHAH proudly maintains its 4-star rating, the highest awarded by Charity Navigator, for the tenth consecutive year. This rating is a testament to its commitment to transparency and efficiency, assuring donors that 95% of every dollar contributed goes directly toward global relief efforts.

Please consider donating to All Hands and Hearts' Ukraine Crisis Relief program. Together, we can make a lasting impact on the lives of war-stricken individuals.

Media Contact: 
Morgan Sydlowski
Director of Marketing at All Hands and Hearts
[email protected]
(+1) 978-518-0489

SOURCE All Hands and Hearts

These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

News published on and distributed by: